Compare TMUS & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMUS | JNJ |
|---|---|---|
| Founded | 1994 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.0B | 542.4B |
| IPO Year | 2004 | 2003 |
| Metric | TMUS | JNJ |
|---|---|---|
| Price | $181.60 | $273.15 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 20 |
| Target Price | ★ $256.65 | $238.20 |
| AVG Volume (30 Days) | 4.4M | ★ 6.6M |
| Earning Date | 04-28-2026 | 04-14-2026 |
| Dividend Yield | 2.06% | ★ 2.36% |
| EPS Growth | 0.62 | ★ 90.50 |
| EPS | ★ 5.26 | 4.41 |
| Revenue | ★ $40,604,000,000.00 | N/A |
| Revenue This Year | $9.27 | $6.63 |
| Revenue Next Year | $4.59 | $7.43 |
| P/E Ratio | ★ $34.55 | $61.91 |
| Revenue Growth | ★ 9.03 | N/A |
| 52 Week Low | $165.66 | $173.33 |
| 52 Week High | $258.66 | $276.47 |
| Indicator | TMUS | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 61.45 |
| Support Level | $168.43 | $247.97 |
| Resistance Level | $199.52 | $274.90 |
| Average True Range (ATR) | 3.93 | 4.89 |
| MACD | 0.54 | 0.73 |
| Stochastic Oscillator | 62.44 | 74.94 |
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves about 86 million postpaid and 26 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 8 million residential and business customers with its wireless network. It also serves 1 million fiber broadband customers through joint ventures with fiber network owners. T-Mobile owns a stake in these firms, which provide wholesale access to their networks. In addition, T-Mobile provides wholesale services to wireless resellers.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.